Case Report
Published on 12 Dec 2023
Case report: Obstructive azoospermia as the first presentation of Von Hippel-Lindau disease
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1296555
- 1,590 views
Type at least 3 characters
1,362 articles
Case Report
Published on 12 Dec 2023
Ossifying renal tumor of infancy: a case report
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1301328
- 1,508 views
Original Research
Published on 11 Dec 2023
Overview and characterization of penile cancer content across social media platforms
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1301973
- 1,831 views
- 1 citation
Case Report
Published on 11 Dec 2023
Case report: 177Lu DOTA-TATE: a new scheme for the treatment of prostate neuroendocrine cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1289272
- 2,386 views
- 2 citations
Systematic Review
Published on 08 Dec 2023
The prognostic value of zonal origin in clinically localized prostate cancer: a systematic review and meta-analysis
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1248222
- 1,819 views
Original Research
Published on 08 Dec 2023
Changes in adhesion molecules: β-catenin, E-cadherin and Galectin-3 in cells of testicular seminoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1269637
- 1,845 views
Editorial
Published on 05 Dec 2023
Editorial: Challenges in the prevention of prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1342733
- 876 views
Original Research
Published on 30 Nov 2023
Incidence trends in prostate cancer among men in the United States from 2000 to 2020 by race and ethnicity, age and tumor stage
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1292577
- 5,166 views
- 6 citations
Original Research
Published on 27 Nov 2023
The values of HER-2 expression in the non-muscle-invasive bladder cancer: a retrospective clinical study
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1243118
- 1,885 views
- 2 citations
Original Research
Published on 23 Nov 2023
TPD52L2 as a potential prognostic and immunotherapy biomarker in clear cell renal cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1210910
- 2,424 views
- 2 citations
Original Research
Published on 23 Nov 2023
Magnetic resonance imaging radiomics-based prediction of clinically significant prostate cancer in equivocal PI-RADS 3 lesions in the transitional zone
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1247682
- 2,624 views
- 5 citations
Original Research
Published on 20 Nov 2023
Differential expression of HIF1A and its downstream target VEGFA in the main subtypes of renal cell carcinoma and their impact on patient survival
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1287239
- 2,766 views
- 4 citations
Original Research
Published on 17 Nov 2023
Impact of healthcare inequities on survival in Mexican patients with metastatic renal cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1229016
- 2,257 views
- 2 citations
Original Research
Published on 17 Nov 2023
Methylation of the epigenetic JMJD2D protein by SET7/9 promotes prostate tumorigenesis
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1295613
- 1,918 views
- 3 citations
Original Research
Published on 10 Nov 2023
Development and validation of a model based on immunogenic cell death related genes to predict the prognosis and immune response to bladder urothelial carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1291720
- 2,957 views
- 3 citations
Original Research
Published on 10 Nov 2023
Development and validation of a combined hypoxia- and metabolism-related prognostic signature to predict clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1162846
- 2,394 views
- 5 citations